Antagonizing CD105 and androgen receptor to target stromal-epithelial interactions for clinical benefit.
Smith BN, Mishra R, Billet S, Placencio-Hickok VR, Kim M, Zhang L, Duong F, Madhav A, Scher K, Moldawer N, Oppenheim A, Angara B, You S, Tighiouart M, Posadas EM, Bhowmick NA.
Smith BN, et al. Among authors: zhang l.
Mol Ther. 2023 Jan 4;31(1):78-89. doi: 10.1016/j.ymthe.2022.08.019. Epub 2022 Aug 31.
Mol Ther. 2023.
PMID: 36045587
Free PMC article.